| 1. |
Mantovani G, Bastepe M, Monk D, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement. Nat Rev Endocrinol, 2018, 14(8): 476-500.
|
| 2. |
Li YL, Han T, Hong F. Cutaneous nodules and a novel GNAS mutation in a chinese boy with pseudohypoparathyroidism type 1a: a case report and review of literature. World J Clin Cases, 2020, 8: 587-593.
|
| 3. |
Maeda K, Sekine O. Reading epilepsy as the initial symptom of idiopathic hypoparathyroidism. Intern Med, 2011, 50(11): 1235-1237.
|
| 4. |
Elli FM, Pereda A, Linglart A, et al. Parathyroid hormone resistance syndromes-inactivating PTH/PTHrP signaling disorders(ippsds). Best Pract Res Clin Endocrinol Metab, 2018, 32: 941-954.
|
| 5. |
Bronsky D, Kushner DS, Dubin A, et al. Idiopathic hypoparathyroidism and pseudohypoparathyroidism: case reports and review of the literature. Medicine, 1958, 37(4): 317-352.
|
| 6. |
邱新光, 王碧霄. 甲状腺术后低钙血症的防治策略. 国际外科学杂志, 2015, 42(1): 7-10.
|
| 7. |
Kline CA, Esekogwu VI, Henderson SO et al. Non-convulsive status epilepticus in a patient with hypocalcemia. J Emerg Med, 1998, 16(5): 715-718.
|
| 8. |
王亚冰, 王鸥, 邢小平. 甲状旁腺功能减退症和假性甲状旁腺功能减退症心血管系统表现. 中华骨质疏松和骨矿盐疾病杂志, 2020, 13(2): 164-171.
|
| 9. |
Yarmohammadi H, Uy-Evanado A, Reinier K, et al. Serum calcium and risk of sudden cardiac arrest in the general population. Mayo Clin Proc, 2017, 92: 1479-1485.
|
| 10. |
Velayuthan S, Gungor N, McVie R. Hypocalcemic cardiomyopathy as initial presentation of primary hypoparathyroidism. Pediatr Int, 2014, 56: e23-e25.
|
| 11. |
Vlot M, de Jong M, de Ronde P, et al. A surprising cause of reversible dilated cardiomyopathy. BMJ Case Rep, 2014, 5: bcr2013203512.
|
| 12. |
Newman DB, Fidahussein SS, Kashiwagi DT, et al. Reversible cardiac dysfunction associated with hypocalcemia: a systematic review and meta-analysis of individual patient data. Heart Fail Rev, 2014, 19: 199-205.
|
| 13. |
Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation, 2005, 112: 2627-2633.
|
| 14. |
Bansal N, Zelnick L, Robinson-Cohen C, et al. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the multi-ethnic study of atherosclerosis. J Am Heart Assoc, 2014, 3: e001278.
|
| 15. |
Hagstrom E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation, 2009, 119: 2765-2771.
|
1/5
WeChat